|
TXLNG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.099400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.900000E-01 |
| Normal-vs-Stage2 |
4.552200E-01 |
| Normal-vs-Stage3 |
6.756700E-03 |
| Normal-vs-Stage4 |
7.424000E-03 |
| Stage1-vs-Stage2 |
1.427210E-01 |
| Stage1-vs-Stage3 |
3.031300E-04 |
| Stage1-vs-Stage4 |
4.768800E-04 |
| Stage2-vs-Stage3 |
2.314800E-01 |
| Stage2-vs-Stage4 |
1.632830E-01 |
| Stage3-vs-Stage4 |
6.963000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.161000E-01 |
| Normal-vs-AfricanAmerican |
2.376000E-01 |
| Normal-vs-Asian |
2.323000E-01 |
| Caucasian-vs-AfricanAmerican |
4.120200E-01 |
| Caucasian-vs-Asian |
1.898830E-01 |
| AfricanAmerican-vs-Asian |
4.706200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.245800E-04 |
| Normal-vs-Female |
3.323100E-03 |
| Male-vs-Female |
1.28160004830846E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.670400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.077600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.851200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.461400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.020000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.618200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.224800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.490600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.099400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.639000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.802000E-02 |
| Normal-vs-Grade 2 |
1.393010E-01 |
| Normal-vs-Grade 3 |
3.301800E-02 |
| Normal-vs-Grade 4 |
1.77577000000095E-05 |
| Grade 1-vs-Grade 2 |
1.409430E-01 |
| Grade 1-vs-Grade 3 |
5.876700E-03 |
| Grade 1-vs-Grade 4 |
4.12469999999665E-05 |
| Grade 2-vs-Grade 3 |
7.430000E-04 |
| Grade 2-vs-Grade 4 |
8.04290000155916E-08 |
| Grade 3-vs-Grade 4 |
9.883600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.480200E-03 |
| Normal-vs-ccB subtype |
2.104000E-02 |
| ccA subtype-vs-ccB subtype |
3.39709999996884E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.890600E-01 |
| Normal-vs-N1 |
4.327600E-02 |
| N0-vs-N1 |
8.697900E-02 |
|
|
